TINF2 and neoplasm: Patients with low tumor TIN2 expression (<36) also had a significantly worse clinical evolution (an EFS of 5 and OS of 6 months) compared with patients with high TIN2 (Figure 2e; EFS of 11 and OS of 32 months; p = 0.015 and p = 0.0018).